| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
1 |
| Liver |
0 |
0.77 |
| Hepatic Fibrosis |
0 |
0.72 |
| Aminotransferase |
0 |
0.63 |
| Fatty Liver |
0 |
0.63 |
| Liver Disease |
0 |
0.63 |
| Metabolic Syndrome |
0 |
0.49 |
| Cirrhosis |
0 |
0.47 |
| Type 2 Diabetes Mellitus |
0 |
0.33 |
| Obesity |
0 |
0.18 |
| Body Mass Index |
0 |
0.17 |
| Cardiometabolic Risk Factors |
0 |
0.14 |
| Biopsy |
0 |
0.13 |
| Lipids Management |
0 |
0.12 |
| Nausea |
0 |
0.09 |
| Steatosis |
0 |
0.09 |
| Triglycerides |
0 |
0.09 |
| Diarrhea |
0 |
0.08 |
| Cardiovascular Risk Management |
0 |
0.07 |
| GLP-1 Receptor Agonist |
0 |
0.07 |
| Hypertension |
0 |
0.07 |
| Hemoglobin A1c |
0 |
0.06 |